Read our latest on-going research as we work to advance the standards of care in our therapeutic areas of focus.
Dose-Proportionality and Steady-State Pharmacokinetics of Serdexmethylphenidate (SDX)/Dexmethylphenidate, a Novel Prodrug Combination to Treat Attention-Deficit/Hyperactivity Disorder
Braeckman R, et al. J Child Adolesc Psychopharmacol. 2022 Jun 3. doi: 10.1089/cap.2022.0015.
View PublicationOral, intranasal, and intravenous abuse potential of serdexmethylphenidate, a novel prodrug of d-methylphenidate
Shram MJ, et al. Curr Med Res Opin. 2022 Jun 3:1-14. doi: 10.1080/03007995.2022.2076474.
View PublicationA Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder
Kollins SH, et al. J Child Adolesc Psychopharmacol. 2021;31(9):597-609.
View PublicationA Retrospective Real-World Analysis Demonstrating the Value of AZSTARYS for Patients With Attention-Deficit Hyperactivity
Faraone S, et al. Presentation. Psych Congress 2022
View PresentationBioequivalence and Safety Comparison of Once-Weekly Donepezil Transdermal System With Oral Donepezil: Results of a Phase 1 Pharmacokinetic Study in Healthy Volunteers
Tariot P, et al. Presentation. AAIC 2022
View PresentationDose Proportionality and Effects of Food on the Pharmacokinetics of Single-Entity Serdexmethylphenidate
Braeckman R, et al. Presentation. APSARD 2022.
View PresentationEvaluation of Skin Adhesion and Local Skin Tolerability of Once-Weekly Donepezil Transdermal System: Results of a Phase 1 Trial in Healthy Volunteers
Tariot P, et al. Presentation. Psych Congress 2022
View PresentationMass Balance and Metabolic Pathway Following Oral Administration of [14C]-Serdexmethylphenidate, a Novel Prodrug of d-Methylphenidate
Braeckman R, et al. Presentation. APSARD 2022.
View PresentationSerdexmethylphenidate/Dexmethylphenidate for Children With Attention-Deficit Hyperactivity Disorder: Reduction in Disorder Severity From a Laboratory Classroom Study
Childress A, et al. Presentation. Psych Congress 2022
View PresentationSerdexmethylphenidate/Dexmethylphenidate Effects on Sleep in Children With Attention-Deficit Hyperactivity Disorder
Mattingly G, et al. Presentation. Psych Congress 2022
View PresentationSerdexmethylphenidate/d-Methylphenidate Capsules for Children With ADHD: Effects on SKAMP-C Evaluated Over 13 Hours in a Randomized, Double-blind, Placebo-controlled Laboratory Classroom Study
Oh C, et al. Presentation. CHADD 2021.
View PresentationSerdexmethylphenidate/d-Methylphenidate Capsules for Children With ADHD: Effects on SKAMP-C and WREMB-R as Evaluated in a Randomized, Double-blind, Placebo-controlled Laboratory Classroom Study
Oh C, et al. Presentation. American Psychiatric Nurses Association 2021.
View PresentationSingle-dose Pharmacokinetics of Serdexmethylphenidate/d-Methylphenidate Capsules in Children and Adolescents With ADHD and Healthy Adults: An Evaluation of Age and Body Weight
Braeckman R, et al. Presentation. AACAP 2021.
View PresentationSteady-State Pharmacokinetics and Relative Bioavailability of Serdexmethylphenidate/d-Methylphenidate, a Treatment for Attention Deficit Hyperactivity Disorder Containing a Novel Prodrug of d-Methylphenidate
Braeckman R, et al. Presentation. Psych Congress 2021.
View Presentation